Replies to post #8933 on Scott Lane

[k9narc]

I'll just say....I'll have what she's smoking.

Here's an analyst recommendation on Aduro Biotech Inc (ADRO)


That's the one I grabbed a bunch of yesterday. I hadn't seen this when I bought.

"Aduro Biotech Inc(ADRO-Q) was rated new "outperform" at Oppenheimer by equity analyst Wendy Lam. The 12-month target price is $30 (U.S.) per share."

Maybe a 10X will cheer me up. Wouldn't be the first time I turned 25K into 250k. ahhhhhh...a good dream.

Off a Globe and mail link that may need a membership to read.

https://www.theglobeandmail.com/globe-investor/inside-the-market/tuesdays-analyst-upgrades-and-downgrades/article26883940/

Still watching your UNVC